Atlas Trials

Retrospective, Observational, Multi-center Study Evaluating the Efficacy and Tolerance of Brigatinib in the Management of Rearranged CBNPC ROS1

Clinical trial NCT04718012 · COMPLETED

Trial details

NCT number
NCT04718012
Sponsor
Centre Hospitalier Intercommunal Creteil
Status
COMPLETED
Study type
OBSERVATIONAL
Lung Cancer ROS Translocated
Start date
2021-03-17
Primary completion
2021-10-17
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.